6 findings from HIMSS 2017 Precision Medicine Study

The combination of precision medicine and information technology (IT) has the potential to improve patient outcomes. But many healthcare organizations are slow to pursue integration. A recently released report, “2017 Precision Medicine Study," from Healthcare Information and Management Systems Society (HIMSS) outlines how healthcare organizations view the expansion and improvement of IT with precision medicine.

The study surveyed 100 professionals in biomedical roles, medical directors and laboratory directors, as well as including data from 5,640 U.S. hospital respondents.

Findings included:

  1. The adoption of precision medicine has fallen from 28.5 percent in 2016 to 26 percent in 2017.
  2. Research organizations or academic medical centers and organizations with more than 500 beds are most likely to implement precision medicine.
  3. 65 percent of organizations selected oncology as the area to implement precision medicine.
  4. Cardiology ranked second at 50 percent for the area of precision medicine implementation, an increase from 28 percent in 2016.
  5. 36 percent of organization use dedication precision medicine platforms and in-house solutions to describe their IT approach to precision medicine, and 24 percent only used current in-house solutions.
  6. 16 percent of organizations in 2017 reported feeling unsure about precision medicine and IT approaches, a significant decrease from 46 percent in 2016.
""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup